Bio-Techne (TECH) Share-based Compensation Growth (1y) (2010 - 2026)
Powered by 
Analysis
Bio-Techne (TECH) Share-based Compensation Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 71.86% |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | -3.46% |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -7.69% |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | -8.89% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | -22.43% |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -4.01% |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 14.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.95% |
| Mar 31, 2026 | 116,471.43% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -105.26% |
| Jun 30, 2025 | -39.50% |
| Mar 31, 2025 | -56.25% |
| Dec 31, 2024 | 9.71% |
| Sep 30, 2024 | -66.07% |
| Jun 30, 2024 | 460.72% |
| Mar 31, 2024 | -29.20% |
| Dec 31, 2023 | 2.10% |
| Sep 30, 2023 | 15.46% |
| Jun 30, 2023 | -116.52% |
| Mar 31, 2023 | 352.00% |
| Dec 31, 2022 | 24.72% |
| Sep 30, 2022 | -71.55% |
| Jun 30, 2022 | -0.38% |
| Mar 31, 2022 | -93.92% |
| Dec 31, 2021 | 151.89% |
| Sep 30, 2021 | -97.37% |